MarketInOut Stock Screener Log In | Sign Up

Orion Oyj Series B

HEL • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Orion Oyj Series B stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHEL
Market Capitalization13,440 mln
Float107 mln
Earnings Date10/28/2026

EPS

4.17
Solid

P / E

23.98
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-1.73
Likely manipulated

1-Year Forecast

85.33
Limited downside

Relative Strength

97 / 100
Top performer

Business Description

Founded in Finland in 1917, Orion Oyj is a pharmaceutical company that creates and sells a wide range of medicines for both people and animals across Europe, North America, and beyond. Its human health portfolio covers treatments for conditions such as prostate cancer, Parkinson's disease, heart failure, asthma, and several other serious illnesses, while its animal health range serves veterinary needs worldwide. The company also produces active pharmaceutical ingredients, offers contract manufacturing, and sells self-care products including vitamins, supplements, and skincare items. Orion works alongside partners such as Bayer and Tenax Therapeutics to develop new treatments, and its products are available through both traditional and online channels.

Key Fundamentals

EPS4.17
P/E23.98
ROE52.28
RPS14.62
ROIC37.71
ROA31.32
Interest Cover195
EBITDA, mln800
EV / EBITDA14.42
EV / EBIT15.59
Revenue, mln2,057
EV / Revenue5.61

Quote Details

Last 100.00
Change 1.6 (1.63%)
Open 99.50
Volume 145,064
Turnover 14,506,400
Average Volume 171,243

Financial Ratios

Pre-Tax Profit Margin36
Leverage Ratio1.48
Current Ratio2.64
Price / Book9.18
Price / Tangible Book10.79
Price / Cash Flow28.60
Price / Free Cash Flow29.62
Debt / Equity0.11
Price / Sales5.66
PEG Ratio1.38

Financial Strength

Altman Z-Score15.2
Piotroski F-Score 7 / 9
Beneish M-Score-1.73
Price to Intrinsic Value2.45
Price to Lynch Fair Value1.05
Price to Graham Number3.08
1-Year Target Price85.33
Shiller PE Ratio37.52

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.34% 95 / 100   
1 Month 24.89% 99 / 100   
2 Months 25.13% 92 / 100   
6 Months 44.55% 91 / 100   
1 Year 67.9% 96 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog